Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(2 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
+ | |||
+ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content</big> | |+<big>WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content</big> | ||
Line 17: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |CHAPTER 2 (PITUITARY TUMOURS) | + | | |
+ | ==== CHAPTER 2 (PITUITARY TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 279: | Line 282: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 3 (THYROID TUMOURS) | + | | |
+ | ==== CHAPTER 3 (THYROID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 574: | Line 578: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 4 (PARATHYROID TUMOURS) | + | | |
+ | ==== CHAPTER 4 (PARATHYROID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 649: | Line 654: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 5 (ADRENAL GLAND TUMOURS) | + | | |
+ | ==== CHAPTER 5 (ADRENAL GLAND TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 779: | Line 785: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) | + | | |
+ | ==== CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 887: | Line 894: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) | + | | |
+ | ==== CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,028: | Line 1,036: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) | + | | |
+ | ==== CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,125: | Line 1,134: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) | + | | |
+ | ==== CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,288: | Line 1,298: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) | + | | |
+ | ==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,385: | Line 1,396: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 11 (GERM CELL TUMOURS) | + | | |
+ | ==== CHAPTER 11 (GERM CELL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,427: | Line 1,439: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 12 (METASTASIS) | + | | |
+ | ==== CHAPTER 12 (METASTASIS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,480: | Line 1,493: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) | + | | |
+ | ==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,502: | Line 1,516: | ||
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]] | |[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]] | |[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]] | |[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]] | ||
Line 1,568: | Line 1,582: | ||
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]] | |[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | |[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] |
Latest revision as of 14:08, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.